Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses
- PMID: 37065886
- PMCID: PMC10098148
- DOI: 10.3389/fpsyt.2023.1141988
Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses
Abstract
Ketamine-assisted psychotherapy is a promising new treatment for a variety of mental disorders of adolescence. There is currently an adolescent mental health crisis, with a high prevalence of disorders, diagnostic complexity, and many adolescents failing to respond to conventional treatments. While there is strong evidence for the use of ketamine in adults for a variety of treatment-refractory mental illnesses, research in adolescents is in its early stages. Ketamine-assisted psychotherapy (KAP) has been described in adults with promising results and here we present the first published cases of the use of KAP in adolescents. The four cases include adolescents aged 14-19 at the initiation of treatment, each with a variety of comorbid diagnoses including treatment-resistant depression, bipolar disorder, eating disorders, anxiety, panic, and trauma-related symptoms. They each initially received sublingual ketamine, followed by sessions with intramuscular ketamine. Their courses varied, but each had symptomatic and functional improvements, and the treatment was well-tolerated. Subjective patient reports are included. Rapid resolution of symptomatology and suffering often occurs within months as the result of the application of KAP to adolescent psychiatric care but is not inevitable. Family involvement in the treatment process appears to be essential to success. The development of this modality may have a singularly positive impact that will expand the psychiatric toolbox and its healing potency.
Keywords: adolescent mental health crisis; adolescent psychiatry; bipolar disorder; eating disorders; ketamine; ketamine-assisted psychotherapy; major depressive disorder; psychedelic psychotherapy.
Copyright © 2023 Wolfson, Andries, Ahlers and Whippo.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Improvement in depressive symptoms in a patient with severe and enduring anorexia nervosa and comorbid major depressive disorder using psychotherapy-assisted IV ketamine : a case report.J Eat Disord. 2024 Jun 12;12(1):79. doi: 10.1186/s40337-024-01039-3. J Eat Disord. 2024. PMID: 38867336 Free PMC article.
-
Ketamine-Assisted Psychotherapy Provides Lasting and Effective Results in the Treatment of Depression, Anxiety, and Post-Traumatic Stress Disorder at 3 and 6 Months: Findings from a Large Retrospective Effectiveness Study.Psychedelic Med (New Rochelle). 2024 Jun 17;2(2):87-95. doi: 10.1089/psymed.2023.0021. eCollection 2024 Jun. Psychedelic Med (New Rochelle). 2024. PMID: 40051583 Free PMC article.
-
Reconnecting through dissociation: a 5-month follow-up case study on ketamine-assisted psychotherapy for anorexia nervosa.J Eat Disord. 2025 Jun 10;13(1):107. doi: 10.1186/s40337-025-01313-y. J Eat Disord. 2025. PMID: 40495248 Free PMC article.
-
Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature.J Pain Res. 2022 Jun 15;15:1691-1706. doi: 10.2147/JPR.S360733. eCollection 2022. J Pain Res. 2022. PMID: 35734507 Free PMC article. Review.
-
A novel framework for ketamine-assisted couple therapy.Front Psychiatry. 2024 Aug 13;15:1376646. doi: 10.3389/fpsyt.2024.1376646. eCollection 2024. Front Psychiatry. 2024. PMID: 39193577 Free PMC article. Review.
Cited by
-
Improvement in depressive symptoms in a patient with severe and enduring anorexia nervosa and comorbid major depressive disorder using psychotherapy-assisted IV ketamine : a case report.J Eat Disord. 2024 Jun 12;12(1):79. doi: 10.1186/s40337-024-01039-3. J Eat Disord. 2024. PMID: 38867336 Free PMC article.
-
Established and emerging treatments for eating disorders.Trends Mol Med. 2024 Apr;30(4):392-402. doi: 10.1016/j.molmed.2024.02.009. Epub 2024 Mar 18. Trends Mol Med. 2024. PMID: 38503683 Free PMC article. Review.
-
The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression.Front Psychiatry. 2023 Sep 19;14:1268832. doi: 10.3389/fpsyt.2023.1268832. eCollection 2023. Front Psychiatry. 2023. PMID: 37795512 Free PMC article.
-
Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective-a new and evolving approach.Front Psychiatry. 2024 Feb 1;15:1209419. doi: 10.3389/fpsyt.2024.1209419. eCollection 2024. Front Psychiatry. 2024. PMID: 38362026 Free PMC article.
-
How Do People Who Undergo Ketamine Treatment for a Psychiatric Problem Subjectively Experience This Intervention? A Meta-Synthesis of Qualitative Studies.Int J Ment Health Nurs. 2025 Feb;34(1):e13425. doi: 10.1111/inm.13425. Epub 2024 Sep 16. Int J Ment Health Nurs. 2025. PMID: 39283006 Free PMC article.
References
-
- Rachtel M. ‘Its Life or Death': The Mental Health Crisis among US Teens. NY Times (2022).
-
- Yard E, Radhakrishnan L, Ballesteros MF, Sheppard M, Gates A, Stein Z, et al. . Emergency department visits for suspected suicide attempts among persons aged 12–25 years before and during the COVID-19 pandemic — United States, January 2019–May 2021. MMWR Morb Mortal Wkly Rep. (2021) 70:888–94. 10.15585/mmwr.mm7024e1 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources